BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.110
+0.070 (3.43%)
May 6, 2026, 10:13 AM EDT - Market open
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $5.1 million as of May 6, 2026. Its market cap has increased by 3.99% in one year.
Market Cap
5.10M
Enterprise Value
1.12M
1-Year Change
3.99%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $5.10M, a decrease of -87.89%. That is a compound annual growth rate of -31.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 4.93M | -47.19% |
| Dec 31, 2025 | 9.34M | 85.79% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Core Molding Technologies | 226.75M |
| Montauk Renewables | 220.59M |
| FutureFuel | 218.44M |
| Flexible Solutions International | 77.06M |
| Northern Technologies International | 76.22M |
| 5E Advanced Materials | 74.31M |
| Loop Industries | 66.22M |
| Bon Natural Life | 7.87M |